|   | 
										시장보고서
									 
											
												상품코드
											
										 
											1780231
										 세계의 조직은행 시장 규모, 점유율, 성장 분석 : 제품별, 조직 유형별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)Tissue Banking Market Size, Share, and Growth Analysis, By Product (Equipment, Cryopreservation Equipment), By Tissue Type (Heart Valves, Cornea), By Application, By End-User, By Region - Industry Forecast 2025-2032 | ||||||
조직은행 세계 시장 규모는 2023년에 43억 달러, 2024년 45억 3,000만 달러에서 2032년에는 68억 4,000만 달러로 성장하고, 예측 기간(2025-2032년) CAGR은 5.3%를 보일 것으로 예측됩니다.
세계 조직은행 시장은 재생의료 수요 증가, 만성질환 환자 증가, 조직 보존 기술 발전에 힘입어 강력한 성장세를 보이고 있습니다. 노령 인구 증가와 조직 제공에 대한 인식이 높아지면서 시장 확대에 크게 기여하고 있습니다. 또한, 정부의 이니셔티브와 의료 인프라에 대한 투자는 전 세계 현대식 바이오뱅크 시설의 발전을 뒷받침하고 있습니다. 북미는 현재 높은 도입률과 유리한 규제 프레임워크로 인해 시장을 독점하고 있지만, 아시아태평양은 의료비 지출 증가와 기증자 인식 제고 프로그램에 힘입어 유리한 지역으로 부상하고 있습니다.
Global Tissue Banking Market size was valued at USD 4.3 Billion in 2023 poised to grow from USD 4.53 Billion in 2024 to USD 6.84 Billion by 2032, growing at a CAGR of 5.3% in the forecast period (2025-2032).
The Global Tissue Banking Market is experiencing robust growth, driven by increasing demand for regenerative medicine, rising cases of chronic diseases, and advancements in tissue preservation technologies. The expanding geriatric population and growing awareness about tissue donation are significantly contributing to market expansion. Additionally, government initiatives and investments in healthcare infrastructure are supporting the development of modern biobanking facilities worldwide. North America currently dominates the market due to high adoption rates and favorable regulatory frameworks, while Asia-Pacific is emerging as a lucrative region, fueled by rising healthcare spending and improved donor awareness programs.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Banking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Tissue Banking Market Segments Analysis
The global tissue banking market is segmented based on application, tissue bank, end use, and region. In terms of application, the market is grouped into regenerative medicine, drug discovery, tissue engineering, and transplantation. Based on the tissue bank, the market is trifurcated into cell bank, organ bank, and tissue bank. Based on end use, the market is segmented into hospitals, research institutions, and pharmaceutical companies. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Central & South America and the Middle East & Africa.
Driver of the Global Tissue Banking Market
A prominent catalyst for the expansion of the global tissue banking market is the increasing need for regenerative medicine. The growing interest in stem cell therapies, tissue transplants, and customized treatments has led to a heightened demand for essential biological materials stored in tissue banks. This surge in demand is driving advancements in tissue preservation technologies and the development of biobanking infrastructures around the world. As healthcare continues to evolve towards more innovative and personalized approaches, the role of tissue banking becomes increasingly vital, facilitating the availability of crucial resources for researchers and clinicians alike.
Restraints in the Global Tissue Banking Market
The expansion of the global tissue banking market faces significant challenges due to ethical and legal issues related to tissue donation, consent, and privacy. The presence of strict regulations and diverse laws across different regions complicates the processes of tissue collection and utilization. This complexity poses difficulties for tissue banks in implementing uniform practices, as they must navigate and comply with local ethical requirements. Consequently, these constraints can limit the availability of tissues for research and therapeutic applications, ultimately hindering the growth and development of this vital sector in healthcare. Maintaining a balance between ethical considerations and operational efficiency remains a critical concern.
Market Trends of the Global Tissue Banking Market
The global tissue banking market is experiencing a notable trend characterized by the increased adoption of automated biobanking systems. This shift towards automation enhances operational efficiency and significantly minimizes human error, resulting in higher preservation quality of biological samples. As institutions strive for innovation and streamlined processes, advanced technologies such as automated tissue collection, storage, and analysis systems are becoming integral to tissue banking operations. This trend not only boosts the reliability of sample handling but also meets the growing demand from research and clinical applications, ultimately contributing to the market's expansion and evolving landscape as stakeholders prioritize precision and efficiency in tissue preservation.